Eyelash trichomegaly: Review of congenital, acquired, and drug-associated etiologies for elongation of the eyelashes

International Journal of Dermatology

Volumn 51, Issue 6, 2012, Pages 631-646

  Paul, Laura J ^a   Cohen, Philip R ^a,b,c   Kurzrock, Razelle ^d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c University of Texas Health Science Center at Houston   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BIMATOPROST; CETUXIMAB; CYCLOSPORIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; LATANOPROST; PANITUMUMAB; PROSTAGLANDIN; TACROLIMUS; TOPIRAMATE; TRAVOPROST; ZIDOVUDINE;

ALLERGY; ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CONGENITAL DISORDER; CONGENITAL HEART DISEASE; DE LANGE SYNDROME; DERMATOMYOSITIS; DISEASE ASSOCIATION; EYELASH; EYELASH TRICHOMEGALY; FAMILIAL DISEASE; HAIR DISEASE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRICHOSIS; HYPOMELANOSIS; KIDNEY CARCINOMA; NEOPLASM; OCULAR ALBINISM; SYSTEMIC LUPUS ERYTHEMATOSUS; UVEITIS; VERNAL CONJUNCTIVITIS;

CONGENITAL ABNORMALITIES; CONJUNCTIVITIS, ALLERGIC; EYELASHES; GENETIC DISEASES, INBORN; HIV INFECTIONS; HUMANS; KIDNEY NEOPLASMS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHARMACEUTICAL PREPARATIONS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SKIN DISEASES; UVEITIS;

EID: 84861312163     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05315.x     Document Type: Article

References (82)

1. Gray H. Trichomegaly or movie lashes. Stanford Med Bull 1944; 2: 157-158.
2. Rubin PAD. Disorders of the eyelashes and eyebrows. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Philadelphia, PA: WB Saunders, 1994: 1851-1859.
3. Bayer A, Bagkesen H, Sobaci G. Acquired trichomegaly in uveitis. Can J Ophthalmol 2007; 42: 101-106.
4. Lacouture ME, Boerner SA, Lorusso PM. Non-rash skin toxicities associated with novel therapies. Clin Lung Cancer 2006; 8: S36-S42.
5. Santmyire-Rosenberger BR, Albert M. Acquired trichomegaly with topiramate. J Am Acad Dermatol 2005; 53: 362-363.
6. Jayamanne DG, Dayan MR, Porter R. Cyclosporin-induced trichomegaly of accessory lashes as a cause of ocular irritation. Nephrol Dial Transplant 1996; 11: 1159-1161.
7. Manjunatha NP, Gnanaraj L. Isolated trichomegaly causing mechanical ptosis. J Pediatr Ophthalmol Strabismus 2008; 45: 384.
8. Woo TL, Francis IC. Intermittent blurred vision and trichomegaly due to latanoprost. Clin Experiment Ophthalmol 2001; 29: 272-273.
9. Casson RJ, Selva D. Lash ptosis caused by latanoprost. Am J Ophthalmol 2005; 139: 932-933.
10. Dueland S, Sauer T, Lund-Johansen F, et al. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003; 42: 345-346.
11. Sasaki S, Hozumi Y, Kondo S. Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol 2005; 14: 323-328.
12. Nazareth MR, Bunimovich O, Rothman IL. Trichomegaly in a 3-year-old girl with alopecia areata. Pediatr Dermatol 2009; 26: 188-193.
13. Aghei S, Dastgheib L. Acquired eyelash trichomegaly and generalized hypertrichosis associated with breast anomaly. Dermatol Online J 2006; 12: 19.
14. Jalili IK. Cone-rod congenital amaurosis associated with congenital hypertrichosis: an autosomal recessive condition. J Med Genet 1989; 26: 504-510.
15. Mansour AM, Bitar FF, Traboulsi EI, et al. Ocular pathology in congenital heart disease. Eye (Lond) 2005; 19: 29-34.
16. Verloes A, Massin M, Fransolet AC, Misson JP. Hypertrichosis, Fallot tetralogy, growth and developmental delay. Clin Dysmorphol 2004; 13: 247-250.
17. Kline AD, Krantz ID, Sommer A, et al. Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A 2007; 143A: 1287-1296.
18. Liu J, Krantz ID. Cornelia de Lange syndrome, cohesin, and beyond. Clin Genet 2009; 76: 303-314.
19. Harrison DA, Mullaney PB. Familial trichomegaly. Arch Ophthalmol 1997; 115: 1602-1603.
20. Osovsky M, Merlob P. Trichomegaly in two sisters with synophrys in the older sibling. Am J Med Genet A 2005; 136A: 398.
21. Ziakas NG, Jogiay A, Michaelides M. A case of familial trichomegaly in association with oculocutaneous albinism type 1. Eye (Lond) 2004; 18: 863-864.
22. Goldstein JH, Hutt AE. Trichomegaly, cataract, and hereditary spherocytosis in two siblings. Am J Ophthalmol 1972; 73: 333-335.
23. Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. Arch Dermatol 1999; 135: 774-780.
24. Shotelersuk V, Gahl WA. Hermansky-Pudlak syndrome: models for intracellular vesicle formation. Mol Genet Metab 1998; 65: 85-96.
25. Witkop CJ, Babcock MN, Rao GH, et al. Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R 1990; 82: 333-339.
26. Oliver GL, McFarlane DC. Congenital trichomegaly: with associated pigmentary degeneration of the retina, dwarfism, and mental retardation. Arch Ophthalmol 1965; 74: 169-171.
27. Chang TS, McFarlane DC, Oliver G, Willis NR. Congenital trichomegaly, pigmentary degeneration of the retina and growth retardation (Oliver-McFarlane syndrome): 28-year follow-up of the first reported case. Can J Ophthalmol 1993; 28: 191-193.
28. Haimi M, Gershoni-Baruch R. Autosomal recessive Oliver-McFarlane syndrome: retinitis pigmentosa, short stature (GH deficiency), trichomegaly, and hair anomalies or CPD syndrome (chorioretinopathy-pituitary dysfunction). Am J Med Genet A 2005; 138A: 268-271.
29. Corby DG, Lowe RS Jr, Haskins RC, Hebertson LM. Trichomegaly, pigmentary degeneration of the retina, and growth retardation. A new syndrome originating in utero. Am J Dis Child 1971; 121: 344-345.
30. Patton MA, Harding AE, Baraitser M. Congenital trichomegaly, pigmentary retinal degeneration, and short stature. Am J Ophthalmol 1986; 101: 490-491.
31. Haritoglou C, Rudolph G, Kalpadakis P, Boergen KP. Congenital trichomegaly (Oliver-McFarlane syndrome): a case report with 9years' follow up. Br J Ophthalmol 2003; 87: 119-120.
32. Mathieu M, Goldfarb A, Berquin P, et al. Trichomegaly, pigmentary degeneration of the retina and growth disturbances. A probably autosomal recessive disorder. Genet Couns 1991; 2: 115-118.
33. González-Enseñat MA, Vicente A, Poo P, et al. Phylloid hypomelanosis and mosaic partial trisomy 13: two cases that provide further evidence of a distinct clinicogenetic entity. Arch Dermatol 2009; 145: 576-578.
34. Almagro M, del Pozo J, García-Silva J, et al. Eyelash length in HIV-infected patients. AIDS 2003; 17: 1695-1696.
35. Marks MB. Recognizing the allergic person. Am Fam Physician 1977; 16: 72-79.
36. Levy Y, Segal N, Ben-Amitai D, Danon YL. Eyelash length in children and adolescents with allergic diseases. Pediatr Dermatol 2004; 21: 534-537.
37. Alpsoy E. Hypotrichosis, long eyelashes and atopic dermatitis: a new syndrome? J Eur Acad Dermatol Venereol 2004; 18: 374-375.
38. Vélez A, Kindelán JM, García-Herola A, et al. Acquired trichomegaly and hypertrichosis in metastatic adenocarcinoma. Clin Exp Dermatol 1995; 20: 237-239.
39. Sharma RC, Mahajan VK, Sharma NL, Sharma A. Trichomegaly of the eyelashes in dermatomyositis. Dermatology 2002; 205: 305.
40. Grossman MC, Cohen PR, Grossman ME. Acquired eyelash trichomegaly and alopecia areata in a human immunodeficiency virus-infected patient. Dermatology 1996; 193: 52-53.
41. Patrizi A, Neri I, Trestini D, et al. Acquired trichomegaly of the eyelashes in a child with human immunodeficiency virus infection. J Eur Acad Dermatol Venereol 1998; 11: 89-91.
42. Tosti A, Gaddoni G, Peluso AM, et al. Acquired hairy pinnae in a patient infected with the human immunodeficiency virus. J Am Acad Dermatol 1993; 28: 513.
43. Graham DA, Sires BS. Acquired trichomegaly associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1997; 115: 557-558.
44. Kaplan MH, Sadick NS, Talmor M. Acquired trichomegaly of the eyelashes: a cutaneous marker of acquired immunodeficiency syndrome. J Am Acad Dermatol 1991; 25: 801-804.
45. Casanova JM, Puig T, Rubio M. Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome. Arch Dermatol 1987; 123: 1599-1601.
46. Janier M, Oksenhendler E, Civatte J. Acquired hypertrichosis of the eyelashes in AIDS. Ann Dermatol Venereol 1989; 116: 559-561.
47. Santiago M, Travassos AC, Rocha MC, Souza S. Hypertrichosis in systemic lupus erythematosus. Clin Rheumatol 2000; 19: 245-246.
48. Pucci N, Novembre E, Lombardi E, et al. Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis. Pediatrics 2005; 115: e86-e91.
49. Wendelin DS, Pope DN, Mallory SB. Hypertrichosis. J Am Acad Dermatol 2003; 48: 161-179.
50. Weaver DT, Bartley GB. Cyclosporine-induced trichomegaly. Am J Ophthalmol 1990; 109: 239.
51. Apaydin C, Gur B, Yakupoglu G, Saka O. Ocular and visual side effects of systemic cyclosporine. Ann Ophthalmol 1992; 24: 465-469.
52. Robert C, Soria JC, Spatz A, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005; 6: 491-500.
53. Lacouture ME, Lai SE. The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome. Br J Dermatol 2006; 155: 852-854.
54. Bouché O, Brixi-Benmansour H, Bertin A, et al. Trichomegaly of the eyelashes following treatment with cetuximab. Ann Oncol 2005; 16: 1711-1712.
55. Cohen PR, Escudier SM, Kurzrock R. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors. Am J Clin Dermatol 2011; 12: 63-67.
56. Drelich DA, Rose L, Ramirez M, et al. Dermatological toxicities of panitumumab in the treatment of patients with metastatic colorectal cancer (mCRC) from three clinical studies [abstract no. 14551]. J Clin Oncol 2007; 25: 629s.
57. Lane K, Goldstein SM. Erlotinib-associated trichomegaly. Ophthal Plast Reconstr Surg 2007; 23: 65-66.
58. Carser JE, Summers YJ. Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer. J Thorac Oncol 2006; 1: 1040-1041.
59. Braiteh F, Kurzrock R, Johnson FM. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. J Clin Oncol 2008; 26: 3460-3462.
60. Zhang G, Basti S, Jampol LM. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of the literature. Cornea 2007; 26: 858-860.
61. Papadopoulos R, Chasapi V, Bachariou A. Trichomegaly induced by erlotinib. Orbit 2008; 27: 329-330.
62. Pascual JC, Bañuls J, Belinchon I, et al. Trichomegaly following treatment with gefitinib (ZD1839). Br J Dermatol 2004; 151: 1111-1112.
63. Sacchi S, Kantarjian H, O'Brien S, et al. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 1995; 13: 2401-2407.
64. Foon KA, Dougher G. Increased growth of eyelashes in a patient given leukocyte A interferon. N Engl J Med 1984; 311: 1259.
65. Foon KA, Roth MS, Bunn PA Jr. Interferon therapy of non-Hodgkin's lymphoma. Cancer 1987; 59: 601-604.
66. Berglund EF, Burton GV, Mills GM, Nichols GM. Hypertrichosis of the eyelashes associated with interferon-alpha therapy for chronic granulocytic leukemia. South Med J 1990; 83: 363.
67. Özdoǧan M, Gür G, Kadayifcilar S, et al. An unusual adverse effect of interferon: hypertrichosis of the eyelashes. J Interferon Cytokine Res 2000; 20: 633-634.
68. Kadayifcilar S, Boyacioǧlu S, Kart H, et al. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye (Lond) 1999; 13: 241-246.
69. Hernández-Núñez A, Fernández-Herrera J, Buceta LR, García-Díez A. Trichomegaly following treatment with interferon alpha-2b. Lancet 2002; 359: 1107.
70. Howaizi M. Pegylated interferon-induced eyelid and eyebrow trichomegaly during chronic hepatitis C. J Gastroenterol Hepatol 2005; 20: 1945-1946.
71. Goksugur N, Karabay O. Eyelash and eyebrow trichomegaly induced by interferon-alfa 2a. Clin Exp Dermatol 2007; 32: 583-584.
72. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral latanoprost. Am J Ophthalmol 1997; 124: 544-547.
73. Demitsu T, Manabe M, Harima N, et al. Hypertrichosis induced by latanoprost. J Am Acad Dermatol 2001; 44: 721-723.
74. Sharif NA, Williams GW, Kelly CR. Bimatoprost and its free acid are prostaglandin FP receptor agonists. Eur J Pharmacol 2001; 432: 211-213.
75. Tosti A, Pazzaglia M, Voudouris S, Tosti G. Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol 2004; 51: S149-S150.
76. Gandolfi S, Simmons ST, Sturm R, et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther 2001; 18: 110-121.
77. Goldberg I, Cunha-Vaz J, Jakobsen JE, et al. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension. J Glaucoma 2001; 10: 414-422.
78. Hempstead N, Hempstead RW. Unilateral trichomegaly induced by bimatoprost ophthalmic solution. J Drugs Dermatol 2004; 3: 571-572.
79. Ward KM, Barnett C, Fox LP, Grossman ME. Eyelash trichomegaly associated with systemic tacrolimus. Arch Dermatol 2006; 142: 248.
80. Klutman NE, Hinthron DR. Excessive growth of eyelashes in a patient with AIDS being treated with zidovudine. N Engl J Med 1991; 324: 1896.
81. Alexandrescu DT, Kauffman CL, Dasanu CA. Persistent hair growth during treatment with the EGFR inhibitor erlotinib. Dermatol Online J 2009; 15: 4.
82. Mechcatie E. Bimatoprost approved for eyelash lengthening. Skin and Allergy News 2009; 40: 10.